A PROSPECTIVE OBSERVATIONAL STUDY ON THE ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTIONS AND MANAGEMENT OF POST-COMPLICATIONS IN STROKE PATIENTS AT A TERTIARY CARE TEACHING HOSPITAL
Keywords:Stroke, Potential drug-drug interactions, Interaction severity, Micromedex, Post-complications
Objective: The objective of the study is to determine the occurrence, frequency, and severity of significant drug-drug interactions in stroke patients, with an emphasis on post complications and their symptomatic management.
Methods: A prospective observational study was carried out for 6 mo at Osmania General Hospital, a Tertiary Care Teaching Hospital. The prescriptions taken by stroke patients throughout their hospital stay were analyzed for possible interactions using-Micromedex-2 (Thomson Reuters) × 2.0.
Results: A total of 130 prescriptions was analyzed in the study in which 141 drug-drug interactions were found with a male predominance of 85.4%. The majority of interactions were of moderate severity (74.46%) and pharmacokinetics (67.37%) in nature. Among the clinical consequences, decreased atorvastatin efficacy (49.10%) was found to be the highest. The class of drugs most commonly involved in drug-drug interactions was found to be anti-epileptics and statins. 60.15% of the study population were identified with one complication, among which seizures account for 15% of patients. All the complications allied with the condition were treated with drug classes in the study population.
Conclusion: This study highlighted the exigency for screening prescriptions of cerebrovascular accident patients for potential drug-drug interactions (pDDIs). Brain edema and seizure were the most accountable complications identified in the study population. The early detection of these problems can improve stroke outcomes and can reduce the mortality or disability rate.
Uppsala Monitoring Centre (UMC). World Health Organization Collaborating Centre for International Drug Monitoring; 2020.
Abideen S, Vivekanandan K, Mishra P. Assessment of the prevalence of potential drug–drug interactions in medical intensive care unit of a tertiary care hospital in India. Asian J Pharm Clin Res. 2015;8:125-313.
Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30:379-407. doi: 10.2165/00002018-200730050-00003, PMID: 17472418
Karen Baxter PCL. Stockley’s drug interactions. 9th ed. London, UK: Pharmaceutical Press; 2010.
Walker R, Whittlesea C. Textbook of clinical pharmacy and therapeutics. 5th ed. 50. New York: Churchill Livingstone; 2012.
Mounica B. A prospective study on drug–drug interactions in the medication charts in general medicine wards, in a tertiary Care Hospital. Guntur, Andhra Pradesh, and the clinical pharmacists role. Int J Biol Pharm Res. 2014:374-7.
Ingeman A, Andersen G, Hundborg HH, Johnsen SP. Medical complications in patients with stroke: data validity in a stroke registry and a hospital discharge registry. Clin Epidemiol. 2010;2:5-13. doi: 10.2147/clep.s8908, PMID 20865097.
Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG, TIA Working Group. Transient ischemic attack--proposal for a new definition. N Engl J Med. 2002;347(21):1713-6. doi: 10.1056/NEJMsb020987, PMID 12444191.
WHO. The top 10 causes of death online address; 2011. Available from: http://www.who.int/mediacentre/factsheets/ fs310/en/index. [Last accessed on 01 Jul 2015].
Doshi VS, Say JH, Young SH, Doraisamy P. Complications in stroke patients: a study carried out at the rehabilitation medicine service, changi general hospital. Med J. 2003;44:643-52.
Dromerick A, Reding M. Medical and neurological complications during inpatient stroke rehabilitation. Stroke. 1994;25(2):358-61. doi: 10.1161/01.str.25.2.358, PMID 8303745.
DRUGDEX® System [database on CD ROM]. Version 5.1. Greenwood Village, CO: Thomson Reuters. Healthcare; 2013.
Anitha N. To estimate the incidence of potential drug-drug interaction in stroke patients admitted in a tertiary Care Hospital. Int J Curr Pharm Res. 2020;12:48-52. doi: 10.22159/ijcpr.2020v12i2.37487.
Thammisetty DP, Ranganayakulu D, Nayakanti D. Drug-related problems and its prescribing indicators in stroke patients: a prospective observational study. Asian J Pharm Clin Res. 2021;14:41-4. doi: 10.22159/ajpcr.2021.v14i3.40529.
Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a South Indian teaching hospital. Australas Med J. 2011;4(1):9-14. doi: 10.4066/AMJ.2011.450, PMID 23393498.
Sharma S, Chhetri HP, Alam K. A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal. Indian J Pharmacol. 2014;46(2):152-6. doi: 10.4103/0253-7613.129303, PMID 24741184.
Sivva D, Mateti UV, Neerati VM, Thiruthopu NS, Martha S. Assessment of drug-drug interactions in hypertensive patients at a super speciality hospital. Avicenna J Med. 2015;5(2):29-35. doi: 10.4103/2231-0770.154194, PMID 25878964.
Mateti UV, Rajakannan T, Nekkanti H, Rajesh V, Mallaysamy SR, Ramachandran P. Drug–drug interactions in hospitalized cardiac patients. J Young Pharm. 2011;3(4):329-33. doi: 10.4103/0975-1483.90246, PMID 22224041.
Kulkarni V, Bora SS, Sirisha S, Saji M, Sundaran S. A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital. Ther Adv Drug Saf. 2013;4(4):141-6. doi: 10.1177/2042098613490009, PMID 25114777.
Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, Faught RE, Haley EC Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke. 1998;29(2):447-53. doi: 10.1161/ 01.str.29.2.447. PMID 9472888.
How to Cite
Copyright (c) 2021 MAHE NAAZ SULTANA, SABA YOUNUS QURESHI, IQRA FATIMA, WAJIDA JABEEN, MOHAMMED OBAID
This work is licensed under a Creative Commons Attribution 4.0 International License.